Wiley Encyclopedia of Chemical Biology 2008
DOI: 10.1002/9780470048672.wecb008
|View full text |Cite
|
Sign up to set email alerts
|

Aminoacyl tRNASynthetases, Chemistry of

Abstract: Aminoacyl‐tRNA synthetases (aaRSs) compose a family of essential enzymes that attach amino acids covalently to tRNA molecules during protein synthesis. Some aaRSs possess a hydrolytic amino acid editing function to ensure the fidelity of protein synthesis. In addition, aminoacylation can occur by indirect pathways that rely on mischarged tRNA intermediates and enzymes other than aaRSs. Throughout evolution, structural and functional divergence of aaRSs has yielded diverse secondary roles. Likewise, aaRS‐like p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2011
2011
2016
2016

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 32 publications
0
3
0
Order By: Relevance
“…Class I RS's aminoacylate the 2 0 -hydroxyl group of the ribose ring of the terminal adenosine of tRNA whereas Class II RS's aminoacylate the 3 0 -hydroxyl group, with the exception of phenylalanine tRNA synthetase (PheRS). 53 Their central cellular function marks aminoacyl tRNA synthetases for therapeutic purposes and most activity in this area has revolved around inhibitors for anti-infective therapy, which has been reviewed. 54 To date, only one aminoacyl tRNA synthetase inhibitor, mupirocin, has been launched onto the market, although there are several promising candidates currently in clinical trials (Fig.…”
Section: Oxaboroles Chemistry and Mechanismmentioning
confidence: 99%
“…Class I RS's aminoacylate the 2 0 -hydroxyl group of the ribose ring of the terminal adenosine of tRNA whereas Class II RS's aminoacylate the 3 0 -hydroxyl group, with the exception of phenylalanine tRNA synthetase (PheRS). 53 Their central cellular function marks aminoacyl tRNA synthetases for therapeutic purposes and most activity in this area has revolved around inhibitors for anti-infective therapy, which has been reviewed. 54 To date, only one aminoacyl tRNA synthetase inhibitor, mupirocin, has been launched onto the market, although there are several promising candidates currently in clinical trials (Fig.…”
Section: Oxaboroles Chemistry and Mechanismmentioning
confidence: 99%
“…Bacterial GlyRS, however, belongs to the subclass IIc, together with PheRS, AlaRS, SepRS, and PylRS, the most heterogeneous group of the three subclasses ( 25 27 ). However, there are some studies that place AlaRS or bacterial GlyRS within subclass IIa and/or do not consider the existence of two types of GlyRS belonging to different subclasses ( 28 32 ).…”
Section: Introductionmentioning
confidence: 99%
“…The ϳ170-amino acid CP1 insertion splits the ATP binding Rossmann-fold that characterizes the aminoacylation active site of class I aminoacyl tRNA synthetases (16,19) and folds discretely into a separate domain. The CP1 domain is connected to the rest of the enzyme via two flexible ␤-strands (Fig.…”
mentioning
confidence: 99%